Efficacy and safety of prophylactic vaccines against cervical HPV infection and diseases among women: a systematic review & meta-analysis.
about
The role of HPV in head and neck cancer and review of the HPV vaccineHuman papillomavirus related cervical cancer and anticipated vaccination challenges in EthiopiaEstimation of Cancer Burden Attributable to Infection in AsiaAre the Two Human Papillomavirus Vaccines Really Similar? A Systematic Review of Available Evidence: Efficacy of the Two Vaccines against HPVHuman papillomavirus vaccination in low-resource countries: lack of evidence to support vaccinating sexually active womenAwareness and knowledge about human papillomavirus vaccination and its acceptance in China: a meta-analysis of 58 observational studiesLong-term efficacy and safety of human papillomavirus vaccinationSafety of human papillomavirus vaccines: a reviewAutoimmune, neurological, and venous thromboembolic adverse events after immunisation of adolescent girls with quadrivalent human papillomavirus vaccine in Denmark and Sweden: cohort studyPrevalence of human papillomavirus in women attending cervical screening in the UK and Ireland: new data from northern Ireland and a systematic review and meta-analysis.Human papillomavirus genotypes in cervical cancer and vaccination challenges in Zimbabwe.See-and-treat approaches to cervical cancer prevention for HIV-infected women.Role of human papillomavirus in oropharyngeal squamous cell carcinoma: A review.Safety of human papillomavirus vaccines in healthy young women: a meta-analysis of 24 controlled studiesHuman papillomavirus (HPV) vaccine policy and evidence-based medicine: are they at odds?Prevalence and molecular epidemiology of human papillomavirus infection in italian women with cervical cytological abnormalities.HPV catch-up vaccination of young women: a systematic review and meta-analysis.Vaccination in elite athletes.The efficacy and duration of vaccine protection against human papillomavirus: a systematic review and meta-analysis.Bacterial immunotherapy of gastrointestinal tumors.Immune responses in macaques to a prototype recombinant adenovirus live oral human papillomavirus 16 vaccine.Efficacy of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical intraepithelial neoplasia and cervical infection in young Japanese women.Evidence of effective delivery of the human papillomavirus (HPV) vaccine through a publicly funded, school-based program: the Ontario Grade 8 HPV Vaccine Cohort Study.Cervical human papillomavirus infection among young women engaged in sex work in Phnom Penh, Cambodia: prevalence, genotypes, risk factors and association with HIV infection.Acceptability and correlates of primary and secondary prevention of cervical cancer among medical students in southwest China: implications for cancer education.A randomized, observer-blinded immunogenicity trial of Cervarix(®) and Gardasil(®) Human Papillomavirus vaccines in 12-15 year old girls.Using HPV vaccination for promotion of an adolescent package of care: opportunity and perspectives.Towards the eradication of HPV infection through universal specific vaccination.Human papillomavirus prevalence and type-distribution in women with cervical lesions: a cross-sectional study in Sri LankaSystematic review and meta-analysis of L1-VLP-based human papillomavirus vaccine efficacy against anogenital pre-cancer in women with evidence of prior HPV exposure.Not the right time: why parents refuse to let their daughters have the human papillomavirus vaccinationHuman papilloma virus vaccines: Current scenario[Efficacy of commercially available vaccines against HPV infection in women: a systematic review and meta-analysis].High Burden of Human Papillomavirus (HPV) Infection among Young Women in KwaZulu-Natal, South AfricaAdolescent Premature Ovarian Insufficiency Following Human Papillomavirus Vaccination: A Case Series Seen in General PracticeAccuracy of optical spectroscopy for the detection of cervical intraepithelial neoplasia without colposcopic tissue information; a step toward automation for low resource settings.Frequency and risk factors for prevalent, incident, and persistent genital carcinogenic human papillomavirus infection in sexually active women: community based cohort studyFuture directions in research, treatment and prevention of HPV-related squamous cell carcinoma of the head and neck.Significantly Reduced Genoprevalence of Vaccine-Type HPV-16/18 Infections among Vaccinated Compared to Non-Vaccinated Young Women 5.5 Years after a Bivalent HPV-16/18 Vaccine (Cervarix®) Pilot Project in Uganda.Evaluation of Association between Vaginal Infections and High-Risk Human Papillomavirus Types in Female Sex Workers in Spain.
P2860
Q24630128-75168167-34C8-44F0-A30E-5E7E35819039Q26752696-555B21C3-45BA-426C-8B09-F482389D6EBAQ26781786-C42272EF-18BA-4238-993F-3AA15436ADD4Q26783973-11594B03-299B-4C04-B546-EFEF3CB420C4Q26824062-0E515215-3D96-4B11-BC47-44548C49135FQ28066373-27DE6874-EF00-4766-9653-E58D3A6A5A2AQ28081156-796FC27D-0B46-4ADC-AC73-C63ABC699213Q28082119-0EB7250F-712E-4840-8B7F-6704E428621BQ28300023-E0EE975D-4019-4EE5-9480-585C70BA037FQ30577846-0ED2F20A-3315-4FD4-A374-7D01F7339CA5Q33638491-5433F938-04D6-40DF-8751-4482547525FCQ33754163-881633EA-D409-493E-A514-C7D84E514E7DQ33770030-D2C71B67-FF55-4FAD-A845-E37D6BDCD13EQ33891821-F96549BE-CA59-4625-AE56-71FD27A659F3Q34029941-7FD138DF-20CC-4CD5-B950-5714C69AFD37Q34074208-D957779C-5F95-43F4-89EB-BF8A745F684FQ34157209-5A01AECA-FA81-4163-ADCD-617AB909EB49Q34227424-1D852BEB-1F04-4EDF-8535-DCDFA753C21EQ34241823-78CEFEE0-8D98-4BF8-9DB0-877D7D19D2C0Q34242204-A2C0BB07-557B-4275-B512-CE340E69AE2AQ34260720-F606DE6E-737F-4D21-B608-CF01062E4177Q34291189-8B59B7AA-6620-4ED2-BE49-983D62B1E961Q34347005-3D390B9F-DB81-48DE-8213-8C21D47C2CCCQ34354553-34F6FBD1-88F1-4415-8432-4EC20F60029BQ34434281-796006E2-D97C-4984-8007-AD8EB18D8AE0Q34708325-B6AB4261-57B0-4B0B-94A7-E280E03CDF51Q34732730-4C2B5929-6057-4E67-9729-14AFC73611E8Q34812959-EA8EBA59-F0A2-48EA-B610-7A5AD7624A90Q35099979-371452AB-91E2-4A0A-8C01-C8C9BB8653B2Q35111092-C2379882-6ADF-48D7-9271-8D62955478E7Q35249483-3039265A-0EC8-421C-A169-53EEA3E6EEF4Q35366075-B44A5548-E60F-4A44-B148-CA36D19B4C67Q35427518-918A59D4-F8C1-4B34-8E7A-98094321E732Q35898044-6DF48244-91DF-41C9-94A2-0F78FE074137Q35927665-CDA6424A-2763-4C1F-AB4F-ABB91500E0CFQ36051726-CBDA8701-7CB1-4349-9253-54E73E1D984DQ36055770-1980C292-A41C-4202-986D-03FDDE450108Q36088069-06B1858D-2456-445F-850C-F38E45051B75Q36092294-3D1026DA-ABFC-41FD-84E6-A2A7A9DC4762Q36151508-D5A9A65C-3C25-41F1-9512-3C718BF76F20
P2860
Efficacy and safety of prophylactic vaccines against cervical HPV infection and diseases among women: a systematic review & meta-analysis.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Efficacy and safety of prophyl ...... ematic review & meta-analysis.
@ast
Efficacy and safety of prophyl ...... ematic review & meta-analysis.
@en
type
label
Efficacy and safety of prophyl ...... ematic review & meta-analysis.
@ast
Efficacy and safety of prophyl ...... ematic review & meta-analysis.
@en
prefLabel
Efficacy and safety of prophyl ...... ematic review & meta-analysis.
@ast
Efficacy and safety of prophyl ...... ematic review & meta-analysis.
@en
P2093
P2860
P31
P921
P356
P1476
Efficacy and safety of prophyl ...... ematic review & meta-analysis.
@en
P2093
Ambuj Kumar
Anna R Giuliano
P2860
P2888
P356
10.1186/1471-2334-11-13
P5008
P577
2011-01-12T00:00:00Z
P5875
P6179
1032864579